Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TEAD
12301
CALL
Teads Holding Co
TEAD
$78.3M
| $20.2K | ﹤0.01% |
+28,700
| New | +$30.4K |
|
12302
CALL
Research Frontiers
REFR
$16.3M
| $20.2K | ﹤0.01% |
15,400
-135,900
| -90% | -$229K |
|
12303
CN Energy Group
CNEY
$5.02M
| $20.2K | ﹤0.01% |
+34,189
| New | +$50.9K |
|
12304
CBL International Ltd
BANL
$9.61M
| $20.1K | ﹤0.01% |
3,483
+892
| +34% | +$6.07K |
|
12305
PUT
CEMIG Preferred Shares
CIG
$6.15B
| $20K | ﹤0.01% |
+10,000
| New | +$20.5K |
|
12306
PUT
Rani Therapeutics
RANI
$92.2M
| $19.8K | ﹤0.01% |
+14,700
| New | +$22.2K |
|
12307
Waldencast
WALD
$198M
| $19.7K | ﹤0.01% |
+10,484
| New | +$21.3K |
|
12308
CALL
Outdoor Holding Co
POWW
$253M
| $19.3K | ﹤0.01% |
11,300
-27,400
| -71% | -$47.1K |
|
|
SAFX
12309
XCF Global Inc
SAFX
$149M
| $19.1K | ﹤0.01% |
+70,067
| New | +$54.5K |
|
12310
PUT
Valens Semiconductor
VLN
$189M
| $19K | ﹤0.01% |
13,400
-19,100
| -59% | -$31.5K |
|
12311
Rackspace Technology
RXT
$1.31B
| $18.8K | ﹤0.01% |
19,383
-455,816
| -96% | -$574K |
|
12312
CALL
MoneyHero
MNY
$40.6M
| $18.8K | ﹤0.01% |
14,900
+600
| +4% | +$787 |
|
12313
PUT
Atossa Therapeutics
ATOS
$23M
| $18.8K | ﹤0.01% |
2,120
-127
| -6% | -$1.61K |
|
12314
CALL
SelectQuote
SLQT
$131M
| $18.8K | ﹤0.01% |
+13,300
| New | +$22.2K |
|
|
WCT
12315
Wellchange Holdings
WCT
$3.95M
| $18.7K | ﹤0.01% |
2,341
+549
| +31% | +$7.26K |
|
|
HMR
12316
Heidmar Maritime Holdings
HMR
$73.2M
| $18.6K | ﹤0.01% |
23,785
+10,739
| +82% | +$12.5K |
|
12317
PSQ Holdings
PSQH
$16.1M
| $18.3K | ﹤0.01% |
+1,188
| New | +$29.4K |
|
12318
Splash Beverage Group
SBEV
$2.21M
| $18.3K | ﹤0.01% |
6,638
+3,531
| +114% | +$21.1K |
|
12319
CALL
Fathom Holdings
FTHM
$28.9M
| $18.3K | ﹤0.01% |
18,100
-71,700
| -80% | -$96.6K |
|
|
MVO
12320
CALL
DELISTED
MV Oil Trust
MVO
| $18.2K | ﹤0.01% |
14,700
-1,500
| -9% | -$4.9K |
|
|
LNAI
12321
Lunai Bioworks
LNAI
$11.6M
| $18.2K | ﹤0.01% |
+2,579
| New | +$23K |
|
12322
Enlivex Ltd
ENLV
$35.5M
| $18K | ﹤0.01% |
1,706
-2,890
| -63% | -$43.1K |
|
|
IVF
12323
INVO Fertility Inc
IVF
$1.88M
| $17.8K | ﹤0.01% |
4,738
+3,067
| +184% | +$53.4K |
|
|
YARW
12324
Yarrow Bioscience, Inc. Common Stock
YARW
$25.3M
| $17.7K | ﹤0.01% |
+611
| New | +$12.3K |
|
|
LNKS
12325
Linkers Industries
LNKS
$1.6M
| $17.6K | ﹤0.01% |
222
+139
| +167% | +$14.4K |
|
Similar funds
Citadel Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Citadel Advisors held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,363 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Citadel Advisors added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Citadel Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Citadel Advisors fully exited WEX in Q4 2025, selling an estimated $131M.
- Citadel Advisors's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Citadel Advisors opened 2,078 new positions and closed 2,191 in Q4 2025.
- Citadel Advisors's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.